Angiotensin-converting enzyme inhibitor-induced angioedema

Cutis. 2013 Jan;91(1):30-5.

Abstract

Angiotensin-converting enzyme (ACE) inhibitors frequently are prescribed for the management of cardiovascular disorders. In addition to their therapeutic potential, ACE inhibitors are associated with numerous adverse effects, some of which may be lethal. Angioedema is an uncommon but serious acute event that may affect any individual taking an ACE inhibitor. This review outlines the advances in our understanding of the pathogenesis, clinical presentation, and management of this medical emergency.

Publication types

  • Review

MeSH terms

  • Angioedema / chemically induced*
  • Angioedema / physiopathology
  • Angioedema / therapy
  • Angiotensin-Converting Enzyme Inhibitors / administration & dosage
  • Angiotensin-Converting Enzyme Inhibitors / adverse effects*
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Cardiovascular Diseases / drug therapy*
  • Cardiovascular Diseases / physiopathology
  • Humans
  • Risk Factors

Substances

  • Angiotensin-Converting Enzyme Inhibitors